Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IM CannabisIMCC -9.10%37 EV-to-OCF is 213.73 as of Jul. 26, 2026. GuruFocus rates IMCC with a GF Score™ of 37/100 and a GF Value™ of $1.27 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 1,008 Drug Manufacturers companies, IM Cannabis ranks worse than 97.52% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, IM Cannabis's Enterprise Value is $10.90 Mil.
IM Cannabis's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $0.05 Mil. Therefore, IM Cannabis's EV-to-OCF for today is 213.73.
The historical rank and industry rank for IM Cannabis's EV-to-OCF or its related term are showing as below:
IMCC'
s EV-to-OCF Range Over the Past 10 Years
Min: -221.24 Med: -3.2 Max: 242.47
Current: 213.73
During the past 13 years, the highest EV-to-OCF of IM Cannabis was 242.47. The lowest was -221.24. And the median was -3.20.
IMCC's EV-to-OCF is ranked worse than 97.52% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 10.565
vs IMCC: 213.73
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
IM Cannabis's PE Ratio (TTM) for today is calculated as:
IM Cannabis's share price for today is $0.116.
IM Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
IM Cannabis EV-to-OCF Related Terms
IM Cannabis EV-to-OCF Historical Data
* Premium members only.
The historical data trend for IM Cannabis's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IM Cannabis EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where IM Cannabis's EV-to-OCF falls into.
IM Cannabis's current Enterprise Value is $10.90 Mil.
IM Cannabis's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IM Cannabis (IMCC) has a EV-to-OCF of 213.73 as of Jul. 26, 2026. According to the industry distribution chart, IM Cannabis ranks #983 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 97.5%.
Is IM Cannabis' EV-to-OCF too high?
IM Cannabis' current EV-to-OCF is 213.73. The Drug Manufacturers industry median EV-to-OCF is 10.57. IM Cannabis' value of 213.73 is 1923% above this industry median. Based on the distribution chart, IM Cannabis ranks #983 out of 1008 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, IM Cannabis has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IM Cannabis' EV-to-OCF compare to CBDY and CPMD?
According to the Drug Manufacturers industry distribution chart, IM Cannabis ranks #983 out of 1008 companies for EV-to-OCF. This places IM Cannabis in the lower half of its industry. The industry median EV-to-OCF is 10.57. IM Cannabis' value of 213.73 is 1923% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.57, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IM Cannabis's current EV-to-OCF of 213.73 is 1923% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IM Cannabis's current EV-to-OCF is 213.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IM Cannabis stock overvalued right now?
Based on GuruFocus' analysis, IM Cannabis (IMCC) is currently considered Possible Value Trap. The stock's GF Value™ is $1.27, compared to a current price of $0.12 — trading 90.9% below its estimated fair value. The current EV-to-OCF is 213.73 and 1923% above the Drug Manufacturers industry median of 10.57. IM Cannabis' overall GF Score™ is 37/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For IM Cannabis (IMCC), the current EV-to-OCF is 213.73 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IM Cannabis (IMCC) Overvalued in 2026?
Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued.
The current stock price of $0.12 is trading 90.9% below its estimated GF Value™ of $1.27.
GuruFocus considers IM Cannabis to be Possible Value Trap.
Key valuation signals for IMCC:
EV-to-OCF: 213.73
GF Value™: $1.27 vs. price of $0.12 (90.9% below fair value)
Industry Position: 1923% above the Drug Manufacturers median (#983 of 1008)
No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
37GF Score
Get the complete analysis for IMCC
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IMCC has been successfully added to your 
